Management is buying the same thing twice: proven demand from one place is being replicated into identified new places r
The model's full reasoning — Q4 2022 call → NOWe need to determine if the transcript describes a situation where a proven instance is being copied into additional places with demand already visible. The question is specific: "currently in the middle of copying a part of its own business that is already working into additional places where the same demand is already visible." That is, a proven unit being replicated now, with demand at destination. Look at the transcript. Management discusses various things: volumes, rate negotiations, acquisitions, injury prevention, automation rollout, GPO rollout. The automation rollout: they are rolling out check-in kiosks, patient portal, etc. They say "we're in the process of rolling that out right now with our largest partnerships." That is a replication of a proven method? But is it a "part of its own business" that is "already working"? They upgraded EMR and are rolling out automated functionality. They mention it's being rolled out at first partnership, learning, then will roll out concurrently. But is that a proven instance? They say "really well received" but it's still in process. Also, is that a "part of its own business" that is being copied? It's more of an operational improvement, not a new business unit. The GPO: they are going live on the 27th, rolling out at 180 locations. That is a new initiative? They say "we're actually going live on the 27th. We're rolling it out at 180 locations starting on the 27th of February." That sounds like a launch, not a proven instance being copied. They haven't proven it yet; it's going live now. So that's not a proven instance. Acquisitions: they are doing acquisitions, but that's not copying a proven unit; it's buying existing businesses. Injury prevention: they have strong growth, but they are not describing standing up new instances of that business in new locations with demand already visible. They mention organic growth, but not a specific replication.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| VSEC | VSE Corporation | Q3 2022 | 2022-10-28 | B+ |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GDS | GDS Holdings Limited | Q2 2021 | 2021-08-17 | C+ |
| TPIC | TPI Composites, Inc. | Q3 2018 | 2018-11-11 | C |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOLD | Amicus Therapeutics, Inc. | Q1 2018 | 2018-05-08 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| VSAT | Viasat, Inc. | Q4 2017 | 2017-05-23 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GDS · Q2 2021 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a clear, present-tense replication of their proven China-based data center platform into new markets (Hong Kong, Macau, Southeast Asia) where demand is already visible and committed. William Huang explicitly references the “proven” China edge-of-town model (land-and-expand MOUs, 500 000 sqm secured pipeline, hyperscale orders already landed) and states they are “currently developing two purpose-built data centers” in Hong Kong (HK1/HK2) with most capacity “already allocated to strategic customers pending contracts,” plus a new building (HK4) under agreement and a heads-of-agreement for HK3, creating “nearly 80 megawatts of purpose-built capacity through to 2027.” For Macau they have a JV to acquire brownfield sites for redevelopment (20 MW).
FOLD · Q1 2018 → YESThe question is about whether management describes the company as currently copying a proven part of its business into additional places where demand is already visible. YES The transcript shows management describing Galafold as a proven commercial offering (Q1 revenue $16.7M, 300% YoY growth, hundreds of patients, high compliance, 7 approvals, 18 countries with pricing/reimbursement) that is now being replicated into additional markets.
TPIC · Q3 2018 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a proven manufacturing operation (existing dedicated lines and plants in the U.S.